Skip to main content
SpringerLink
Log in

When managing an unprovoked first seizure in adults, carefully consider the benefits and risks of initiating antiepileptic treatment

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

Abstract

Following the occurrence of an unprovoked first seizure in adults, the risk of seizure recurrence is greatest within the next 2 years. Although immediate antiepileptic drug therapy will not improve the longer-term (>3 years) prognosis for seizure remission, it will reduce the risk of seizure recurrence over the first 2 years. An individualized treatment plan that considers the likelihood of seizure recurrence versus the risks of adverse events should be adopted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Hauser WA, Beghi E. First seizure definitions and worldwide incidence and mortality. Epilepsia. 2008;49(Suppl 1):8–12.

    Article  PubMed  Google Scholar 

  2. Gloss DS, Krumholz A. Managing an unprovoked first seizure in adults. CNS Drugs. 2016;30(3):179–83.

    Article  PubMed  Google Scholar 

  3. Krumholz A, Shinnar S, French J, et al. Evidence-based guideline: management of an unprovoked first seizure in adults. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2015;85(17):1526–7.

    Article  PubMed  Google Scholar 

  4. Krumholz A, Wiebe S, Gronseth G, et al. Practice parameter: evaluating an apparent unprovoked first seizure in adults (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2007;69(21):1996–2007.

    Article  CAS  PubMed  Google Scholar 

  5. Firkin AL, Marco DJ, Saya S, et al. Mind the gap: multiple events and lengthy delays before presentation with a “first seizure”. Epilepsia. 2015;56(10):1534–41.

    Article  PubMed  Google Scholar 

  6. Hauser WA, Rich SS, Lee JR, et al. Risk of recurrent seizures after two unprovoked seizures. N Engl J Med. 1998;338(7):429–34.

    Article  CAS  PubMed  Google Scholar 

  7. Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure. First Seizure Trial Group (FIR.S.T. Group) Neurology. 1993;43(3 Pt 1):478–83.

  8. Marson A, Jacoby A, Johnson A, et al. Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomized controlled trial. Lancet. 2005;365(9476):2007–13.

    Article  CAS  PubMed  Google Scholar 

  9. Chandra B. First seizure in adults: to treat or not to treat. Clin Neurol Neurosurg. 1992;94(Suppl):S61–3.

    Article  PubMed  Google Scholar 

  10. Gilad R, Lampl Y, Gabbay U, et al. Early treatment of a single generalized tonic-clonic seizure to prevent recurrence. Arch Neurol. 1996;53(11):1149–52.

    Article  CAS  PubMed  Google Scholar 

  11. Ruggles KH, Haessly SM, Berg RL. Prospective study of seizures in the elderly in the Marshfield Epidemiologic Study Area (MESA). Epilepsia. 2001;42Z(12):1594–9.

    Google Scholar 

  12. Jacoby A, Gamble C, Doughty J, et al. Quality of life outcomes of immediate or delayed treatment of early epilepsy and single seizures. Neurology. 2007;68(15):1188–96.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

    Consortia

    Adis Medical Writers

    Ethics declarations

    The article was adapted from CNS Drugs 2016;30(3):179–83 [2] by salaried employees of Adis/Springer and was not supported by any external funding.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Adis Medical Writers. When managing an unprovoked first seizure in adults, carefully consider the benefits and risks of initiating antiepileptic treatment. Drugs Ther Perspect 32, 434–436 (2016). https://doi.org/10.1007/s40267-016-0323-4

    Download citation

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s40267-016-0323-4

    Keywords

    Search

    Navigation